Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 7/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | BCAT1 | P54687 | 3/20 | 0.35 |
| ▸ | BCAT2 | O15382 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3825548 | 0.92 | MAPK8 (0.35) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL22912498 | 0.91 | MAPK8 (0.35) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL22912499 | 0.90 | ROCK2 (0.34) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL4572164 | 0.90 | BCAT1 (0.38) | BCAT1BCAT2METDHODH | |
| SCHEMBL6637334 | 0.89 | PPOX (0.34) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL26113051 | 0.88 | BCAT1 (0.34) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL6639709 | 0.88 | MAPK8 (0.35) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL2594502 | 0.88 | BCAT1 (0.41) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| Benzene SCHEMBL21843346 | 0.87 | BCAT1 (0.34) | UGCGCYP3A4MAPK8BCAT1BCAT2 | |
| SCHEMBL29709277 | 0.87 | BCAT1 (0.34) | UGCGCYP3A4MAPK8BCAT1BCAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293979-B2 | Weed controller metabolism proteins, genes, thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| EP-2453018-A1 | A herbicide metabolizing protein, a gene thereof and use thereof | Sumitomo Chemical Company, Limited (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-20100313300-A1 | WEED CONTROLLER METABOLISM PROTEINS, GENES, THEREOF AND USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED | 2010-12-09 | — | — | US | disclosed |
| US-7745699-B2 | Weed controller metabolism proteins, genes thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100313300-A1 | WEED CONTROLLER METABOLISM PROTEINS, GENES, THEREOF AND USE OF THE SAME | HADHB, WEE1, AS3MT | UGCG 2447/4885CYP3A4 367/4885MAPK8 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.